These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1059 related articles for article (PubMed ID: 9723960)

  • 21. Superoxide and its interaction with nitric oxide modulates renal function in prehypertensive Ren-2 transgenic rats.
    Kopkan L; Husková Z; Vanourková Z; Thumová M; Skaroupková P; Cervenka L; Majid DS
    J Hypertens; 2007 Nov; 25(11):2257-65. PubMed ID: 17921820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II-induced myocardial fibrosis in rats: role of nitric oxide, prostaglandins and bradykinin.
    Sigusch HH; Campbell SE; Weber KT
    Cardiovasc Res; 1996 Apr; 31(4):546-54. PubMed ID: 8689646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
    El-Mas MM; Mohy El-Din MM; El-Gowilly SM; Sharabi FM
    Eur J Pharmacol; 2004 Mar; 487(1-3):149-58. PubMed ID: 15033387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
    Henrion D; Dechaux E; Dowell FJ; Maclour J; Samuel JL; Lévy BI; Michel JB
    Br J Pharmacol; 1997 May; 121(1):83-90. PubMed ID: 9146891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
    Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Casal MC; Cachofeiro V; Lahera V
    J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats.
    Vanecková I; Kramer HJ; Novotná J; Kazdová L; Opocenský M; Bader M; Ganten D; Cervenka L
    Kidney Blood Press Res; 2005; 28(2):117-26. PubMed ID: 15795515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II augments renal vasoconstriction via AT1 receptors in L-NAME-induced hypertensive rats.
    Rivera-Jardón FF; Castro-Moreno P; Figueroa-Guillén ES; Gallardo-Ortíz IA; Godínez-Hernández D; Ibarra-Barajas M
    Proc West Pharmacol Soc; 2009; 52():47-9. PubMed ID: 22128421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between prostanoids and nitric oxide in the control of tubular function in rats with chronic bile duct ligation.
    Criado M; Flores O; Hidalgo F; López-Novoa JM; Sánchez-Rodríguez A
    Can J Physiol Pharmacol; 1999 Feb; 77(2):111-7. PubMed ID: 10535701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II-induced renal responses in anesthetized rabbits: effects of N omega-nitro-L-arginine methyl ester and losartan.
    Adachi Y; Hashimoto K; Hisa H; Yoshida M; Suzuki-Kusaba M; Satoh S
    Eur J Pharmacol; 1996 Jul; 308(2):165-71. PubMed ID: 8840128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in angiotensin AT1 receptor mRNA levels in the rat brain after immobilization stress and inhibition of central nitric oxide synthase.
    Kiss A; Jurkovicova D; Jezova D; Krizanova O
    Endocr Regul; 2001 Jun; 35(2):65-70. PubMed ID: 11563933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of L-NOARG and L-NAME on basal blood flow and ACh-induced vasodilatation in rat diaphragmatic microcirculation.
    Chang HY; Chen CW; Hsiue TR
    Br J Pharmacol; 1997 Jan; 120(2):326-32. PubMed ID: 9117127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II natriuresis and anti-natriuresis: role of renal artery pressure in anaesthetized dogs.
    Olsen ME; Hall JE; Montaini JP; Guyton AC
    J Hypertens Suppl; 1984 Dec; 2(3):S347-50. PubMed ID: 6599679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric oxide and prostacyclin are involved in antithrombotic action of captopril in venous thrombosis in rats.
    Pawlak R; Chabielska E; Golatowski J; Azzadin A; Buczko W
    Thromb Haemost; 1998 Jun; 79(6):1208-12. PubMed ID: 9657449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X; Matavelli LC; Ono H; Frohlich ED
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pressor and renal vasoconstrictor effects of NG-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin.
    Pucci ML; Lin L; Nasjletti A
    J Pharmacol Exp Ther; 1992 Apr; 261(1):240-5. PubMed ID: 1560371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of the renal effects of contrast media by endothelium-derived nitric oxide in the rat.
    Touati C; Idee JM; Deray G; Santus R; Balut C; Beaufils H; Jouanneau C; Bourbouze R; Doucet D; Bonnemain B
    Invest Radiol; 1993 Sep; 28(9):814-20. PubMed ID: 8225887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-II-induced increase in transcoronary protein clearance: role of hypertension vs. nitric oxide or cyclo-oxygenase products.
    Sigusch HH; Ou R; Katwa LC; Campbell SE; Ganjam VK; Reddy HK; Weber KT
    Cardiovasc Res; 1995 Aug; 30(2):291-8. PubMed ID: 7585817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of preglomerular vessels from angiotensin II vasoconstriction by renal prostaglandins.
    Olsen ME; Hall JE; Montani JP; Cornell JE
    J Hypertens Suppl; 1985 Dec; 3(3):S255-8. PubMed ID: 2856712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide mediates the inhibitory action of platelet-activating factor on angiotensin II-induced renal vasoconstriction, in vivo.
    Handa RK; Strandhoy JW
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1486-91. PubMed ID: 8667214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of NG-nitro-L-arginine methyl ester, the nitric oxide synthase inhibitor, on duodenal alkaline secretion and mepirizole-induced duodenal lesions in rats.
    Takeuchi K; Takehara K; Kato S
    J Clin Gastroenterol; 1995; 21 Suppl 1():S66-72. PubMed ID: 8774993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.